Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 57103-68-1
2. Zwj9a2aj2u
3. Nsc-239386
4. Refchem:156011
5. 950-267-0
6. Unii-zwj9a2aj2u
7. Ansamitocin P-0
8. 3-o-de(2-(acetylmethylamino)-1-oxopropyl)maytansine
9. Mfcd28144515
10. (14s,16s,32s,33s,2r,4s,10e,12e,14r)-86-chloro-14,4-dihydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-diene-12,6-dione
11. Maytansine, 3-o-de(2-(acetylmethylamino)-1-oxopropyl)-
12. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-6,21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaene-8,23-dione
13. C28h37cln2o8
14. Ansamitocin P 0
15. Ansamitocin P 0; Antibiotic C 15003p0; Nsc 239386; 3-o-de[2-(acetylmethylamino)-1-oxopropyl]maytansine
16. Maytansinol; Ansamitocin P-0
17. Maytansinol(ansamitocin P-0)?
18. Schembl13558643
19. Qwpxbehqfhactk-rzkxnlmusa-n
20. Ex-a2656
21. Cs-5322
22. Fm44850
23. Hy-19474
24. 3-o-de[2-[methyl(acetyl)amino]-1-oxopropyl]maytansine
| Molecular Weight | 565.1 g/mol |
|---|---|
| Molecular Formula | C28H37ClN2O8 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 130 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 993 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
54
PharmaCompass offers a list of Maytansinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Maytansinol manufacturer or Maytansinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Maytansinol manufacturer or Maytansinol supplier.
A Maytansinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Maytansinol, including repackagers and relabelers. The FDA regulates Maytansinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Maytansinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Maytansinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Maytansinol supplier is an individual or a company that provides Maytansinol active pharmaceutical ingredient (API) or Maytansinol finished formulations upon request. The Maytansinol suppliers may include Maytansinol API manufacturers, exporters, distributors and traders.
click here to find a list of Maytansinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Maytansinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Maytansinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Maytansinol GMP manufacturer or Maytansinol GMP API supplier for your needs.
A Maytansinol CoA (Certificate of Analysis) is a formal document that attests to Maytansinol's compliance with Maytansinol specifications and serves as a tool for batch-level quality control.
Maytansinol CoA mostly includes findings from lab analyses of a specific batch. For each Maytansinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Maytansinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Maytansinol EP), Maytansinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Maytansinol USP).
